Schedule of Investor Warrants (Details) - Investor Warrant [Member] - shares |
9 Months Ended | 12 Months Ended | |
|---|---|---|---|
Sep. 30, 2023 |
Dec. 31, 2022 |
Dec. 31, 2021 |
|
| Class of Warrant or Right [Line Items] | |||
| Shares outstanding, Beginning balance | 6,147,898 | 3,246,690 | |
| Weighted Average Exercise Price, Outstanding, Beginning balance | 1.45 | 2.26 | |
| Outstanding (in shares) | 2 years 6 months | 2 years 3 months 7 days | 3 years 7 months 2 days |
| Warrants, Granted | 5,715,697 | 6,089,398 | |
| Warrants, Exercised | (5,548,463) | (3,188,190) | |
| Warrants, Canceled/forfeited/expired | |||
| Shares outstanding, Ending balance | 6,315,132 | 6,147,898 | 3,246,690 |
| Weighted Average Exercise Price, Outstanding, Ending balance | 1.62 | 1.45 | 2.26 |
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award equity instruments other than options outstanding weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award equity instruments other than options outstanding weighted average remaining contractual term. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were either cancelled or expired. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|